All News

The recommendation comes more than six years after sparking controversy over the need for annual mammograms.

Cometriq significantly improved progression-free survival versus Afinitor in patients with renal cell carcinoma regardless of the degree of metastases, type or number of prior treatments, or patient risk status.

In an interview with CURE, John C. Byrd discusses the efficacy of acalabrutinib and how it compares with Imbruvica.

December 10 was my New Year's Eve — it was full of hope and renewal.

There is a constellation of factors that will determine your health. Your body, mind and environment are all important variables. Here are my thoughts and what I plan to do in 2016.

A recent study has found that the majority of women at an increased risk of developing breast cancer either refuse or do not adhere to preventive treatment.

Breast cancer survivor ponders her chemo brain and her hair loss several years out from chemotherapy.

It's not always easy to keep on living when you've been told that you are dying.

To gain insight into the research needed in glioblastoma, we interviewed Robert M. Prins, an associate professor in residence at UCLA.

In the first days of my recovery, someone said to me, "Breast cancer in men is exceedingly rare. You're famous!"

Being a pacifist in the war on cancer stands for striving for inner peace and reducing the amount of stress associated with a life-altering illness.

I couldn't figure out how to fit in before this post. I read the blogs in the CURE community of contributors and I read the articles on the CURE home page — nothing.

In a world where cancer means loss, can letting go bring peace and joy?

Targeted drugs, as well as immunotherapies, are beginning to change the treatment outlook for people with advanced non-small cell lung cancer.

A survivor of breast cancer and melanoma reflects on her simple New Year's resolutions.

This time of year, one of the traditions that coincides with resolutions, is the reflection on what we have to be thankful for. This experience — counting blessings, giving thanks, the gratitude attitude — can be challenging.

Staying hopeful when others are dying of the same disease is one of the most challenging aspects of cancer.

A cancer survivor and clutter clearing expert shares ways to clear the holiday clutter.

The FDA has expanded the approval for single-agent Keytruda to include the frontline treatment of patients with advanced melanoma regardless of BRAF status and to include the treatment of patients with Yervoy-refractory melanoma.

Intimacy in the life of a breast cancer survivor can be difficult, but it's not impossible.

In keeping a chronology of our moments of illness, we find ways to commemorate our life moments, both good and bad. We learn who we are, who we want to be and who we will become.

The CD38 monoclonal antibody Darzalex demonstrated a 31 percent overall response rate as monotherapy for patients with heavily pretreated multiple myeloma.

An all orally administered regimen containing Ninlaro, Revlimid and dexamethasone showed a 5.9-month improvement in progression-free survival compared with Revlimid and dexamethasone alone.

Never underestimate the power and inner strength of a hungry cancer patient.

A male breast cancer survivor recalls remarkable gifts of goodwill.

A breast cancer survivor wonders when it will be “safe” to toss the chemo wig and reflects about going down the road as a cancer survivor.

All of the women in the study had progressed on two or more HER2-targeted therapies, including Herceptin (trastuzumab) and Tykerb (lapatinib).

Gene therapy has the potential to deliver long-lasting remissions for patients with advanced B-cell malignancies who already have undergone an allogeneic hematopoietic stem cell transplant.